Cheng S, Chang S, Li Y, Novoseltseva A, Lin S, Wu Y
Light Sci Appl. 2025; 14(1):57.
PMID: 39833166
PMC: 11746934.
DOI: 10.1038/s41377-024-01658-0.
Lam I, Ndayisaba A, Lewis A, Fu Y, Sagredo G, Kuzkina A
Neuron. 2024; 112(17):2886-2909.e16.
PMID: 39079530
PMC: 11377155.
DOI: 10.1016/j.neuron.2024.06.002.
Boing C, Di Fabrizio M, Burger D, Bol J, Huisman E, Rozemuller A
Brain. 2024; 147(11):3727-3741.
PMID: 38696728
PMC: 11531854.
DOI: 10.1093/brain/awae137.
Cheng S, Chang S, Li Y, Novoseltseva A, Lin S, Wu Y
Res Sq. 2024; .
PMID: 38562721
PMC: 10984089.
DOI: 10.21203/rs.3.rs-4014687/v1.
Jellinger K
Free Neuropathol. 2023; 1.
PMID: 37283673
PMC: 10209915.
DOI: 10.17879/freeneuropathology-2020-2813.
Multiple system atrophy.
Poewe W, Stankovic I, Halliday G, Meissner W, Wenning G, Pellecchia M
Nat Rev Dis Primers. 2022; 8(1):56.
PMID: 36008429
DOI: 10.1038/s41572-022-00382-6.
Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathies.
Moors T, Mona D, Luehe S, Duran-Pacheco G, Spycher L, Mundigl O
Acta Neuropathol Commun. 2022; 10(1):82.
PMID: 35659116
PMC: 9164351.
DOI: 10.1186/s40478-022-01382-z.
A historical review of multiple system atrophy with a critical appraisal of cellular and animal models.
Marmion D, Peelaerts W, Kordower J
J Neural Transm (Vienna). 2021; 128(10):1507-1527.
PMID: 34613484
PMC: 8528759.
DOI: 10.1007/s00702-021-02419-8.
An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention.
Chelban V, Catereniuc D, Aftene D, Gasnas A, Vichayanrat E, Iodice V
J Neurol. 2020; 267(9):2754-2770.
PMID: 32436100
PMC: 7419367.
DOI: 10.1007/s00415-020-09881-6.
α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb.
Rey N, Bousset L, George S, Madaj Z, Meyerdirk L, Schulz E
Acta Neuropathol Commun. 2020; 7(1):221.
PMID: 31888771
PMC: 6937797.
DOI: 10.1186/s40478-019-0859-3.
Orthostatic Hypotension in Parkinson Disease.
Palma J, Kaufmann H
Clin Geriatr Med. 2019; 36(1):53-67.
PMID: 31733702
PMC: 7029426.
DOI: 10.1016/j.cger.2019.09.002.
Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.
Palma J, Kaufmann H
Mov Disord. 2018; 33(3):372-390.
PMID: 29508455
PMC: 5844369.
DOI: 10.1002/mds.27344.
Multiple system atrophy: experimental models and reality.
Overk C, Rockenstein E, Valera E, Stefanova N, Wenning G, Masliah E
Acta Neuropathol. 2017; 135(1):33-47.
PMID: 29058121
PMC: 6156777.
DOI: 10.1007/s00401-017-1772-0.
as-PSOCT: Volumetric microscopic imaging of human brain architecture and connectivity.
Wang H, Magnain C, Wang R, Dubb J, Varjabedian A, Tirrell L
Neuroimage. 2017; 165:56-68.
PMID: 29017866
PMC: 5732037.
DOI: 10.1016/j.neuroimage.2017.10.012.
Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.
Jellinger K
J Alzheimers Dis. 2017; 62(3):1141-1179.
PMID: 28984582
PMC: 5870010.
DOI: 10.3233/JAD-170397.
Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
Mandel R, Marmion D, Kirik D, Chu Y, Heindel C, McCown T
Acta Neuropathol Commun. 2017; 5(1):47.
PMID: 28619074
PMC: 5473003.
DOI: 10.1186/s40478-017-0451-7.
Multiple system atrophy: pathogenic mechanisms and biomarkers.
Jellinger K, Wenning G
J Neural Transm (Vienna). 2016; 123(6):555-72.
PMID: 27098666
DOI: 10.1007/s00702-016-1545-2.
Animal modeling an oligodendrogliopathy--multiple system atrophy.
Bleasel J, Halliday G, Kim W
Acta Neuropathol Commun. 2016; 4:12.
PMID: 26860328
PMC: 4748629.
DOI: 10.1186/s40478-016-0279-6.
